Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
Park City, Utah-based Distal Access created a new tissue resection device to easily remove uterine polyps.
Tesaro's experimental ovarian cancer drug niraparib proved to significantly lengthen progression-free survival time in patients during a recent Stage 3 trial.
Shire's experimental drug to treat attention-deficit hyperactive disorder showed positive results in a recent study, bringing the company one step closer to earning approval from the Food and Drug Administration.
Richard Padzur, MD, will head the Oncology Center of Excellence, a program created under Vice President Joe Biden's Cancer Moonshot initiative to accelerate cancer research.
The Food and Drug Administration denied Lipocine's New Drug Application for its oral testosterone drug.
The Food and Drug Administration should eliminate its approve/disapprove method of reviewing new drug applications and instead use a Consumer Reports approach that is based on drug ratings, according to a column in the Wall Street Journal by John Sotos,…
Dublin, Ireland-based Medtronic recently filed for FDA approval on its new artificial pancreas device and expects to introduce the product to the market in 2017, according to Bloomberg.
The Food and Drug Administration on Tuesday approved Gilead Sciences' combination drug as the first available treatment for all six forms of hepatitis C.
The current healthcare environment is dynamic and challenging. Hospital System leadership needs to develop a strategy to improve care while reducing costs.
Sean O. OâNeill, Principal and Healthcare Practice Lead, St. Onge Company
Orig3n, a Boston-based biotech company, is partnering with the San Francisco 49ers to reward football fans who support the company's human genome research.